2017 Annual Meeting

Papanicolaou Society of Cytopathology

March 4 2017, 7:00pm to 10:00pm

Description

Papanicolaou Society of Cytopathology

The Current State of Thyroid Fine-Needle Aspiration: Considerations, Discussions and Conclusions

Saturday, March 4, 2017
7:00 PM 10:00 PM
CC Hemisfair 3

 

Session Credits: 3 CME and 3 SAMs

 

Moderator: Zubair W. Baloch, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

Course Description:
The PSC companion program for 2017 USCAP annual meeting will address new aspects and challenges that may lead to modification in the diagnosis and classification of thyroid FNA specimens.  The subject experts presenting at this companion session will deliver educational content designed to highlight the importance of the pathologist's role in the diagnosis and further intervention and treatment of thyroid nodules. The first speaker will address various cytomorphologic features that distinguish between thyroid nodules classified as suspicious or consistent with papillary thyroid carcinoma. The second presentation will focus on how to make sense and incorporate the "American Thyroid Association" guidelines for management of thyroid nodules into daily practice of thyroid cytology. The third presenter will provide an overview of what is new and exciting in the field of molecular testing of thyroid FNA specimens with emphasis on next generation sequencing. The final presentation will provide an overview of the changes (to be expected) in the second edition of Bethesda System for Reporting Thyroid Cytology.

Upon completion of this educational activity, participants should be able to:

  • Describe key diagnostic features of thyroid FNA specimens classified as suspicious and malignant including diagnostic pitfalls
  • Identify the role of molecular tests, especially those which employ next generation sequencing in the management of thyroid nodules
  • Measure the impact of proposed changes in the Bethesda Thyroid FNA Classification Scheme on your practice of thyroid FNA cytology

Agenda

7:00 PM

Introduction of Program and Speakers
Zubair Baloch, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

7:15 PM

PSC Awards Presentation
Tarik Elsheikh, MD, Cleveland Clinic, Cleveland, OH

7:30 PM

Cytomorphologic Thresholds for Classifying Thyroid FNA Specimens as “Suspicious and Positive for Papillary Thyroid Carcinoma”
Tarik M. Elsheikh, MD, Cleveland Clinic, Cleveland, OH

8:00 PM

Understanding the Current ATA Guidelines for Thyroid Nodule Management and Their Impact on The Bethesda System for Reporting Thyroid Cytology (TBSRTC)
Jeffrey F. Krane, MD, PhD, Brigham & Women’s Hospital, Boston, MA

8:30 PM

Next Generation Sequencing and Thyroid FNA; Utility, Implementation and Pitfalls
Marina N. Nikiforova, MD, FCAP, University of Pittsburgh Medical Center, Pittsburgh, PA

9:00 PM

Proposed Modifications and Updates for the Thyroid Bethesda System for Reporting Thyroid Cytology from an International Panel
William C. Faquin, MD, PhD, Massachusetts General Hospital, Boston, MA

9:30 PM

Concluding remarks and discussion
Zubair Baloch, MD, PhD, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA

 

Meetings

home-circle-inset-1
view more